antiviral
Genome Replication and Regulation of Viral Gene Expression | SpotlightPhosphorylated VP30 of Marburg Virus Is a Repressor of TranscriptionThe largest outbreak of MARV occurred in Angola in 2004 to 2005 and had a 90% case fatality rate. There are no approved treatments available for MARV. Development of antivirals as therapeutics requires a fundamental understanding of the viral life cycle. Because of the close similarity of MARV to another member of Filoviridae family, EBOV, it was assumed that the two...
Virus-Cell Interactions | SpotlightNeuralized E3 Ubiquitin Protein Ligase 3 Is an Inducible Antiviral Effector That Inhibits Hepatitis C Virus Assembly by Targeting Viral E1 GlycoproteinThe exact biological function of NEURL3, a putative E3 ligase, remains largely unknown. In this study, we found that NEURL3 could be upregulated upon HCV infection in a manner dependent on pattern recognition receptor-mediated innate immune response. NEURL3 inhibits HCV assembly by directly binding viral E1 envelope glycoprotein to disrupt its interaction with E2, an action that requires its Neuralized homology repeat (NHR) domain but...
- Virus-Cell Interactions | SpotlightSecretome Screening Reveals Fibroblast Growth Factors as Novel Inhibitors of Viral Replication
Viruses infect human cells in order to replicate, while human cells aim to resist infection. Several cellular antiviral programs have therefore evolved to resist infection. Knowledge of these programs is essential for the design of antiviral therapeutics in the future. The induction of antiviral programs is often initiated by secreted proteins, such as interferons. We hypothesized that other secreted proteins may also promote resistance...
- Pathogenesis and ImmunityTRIM41-Mediated Ubiquitination of Nucleoprotein Limits Influenza A Virus Infection
Influenza control strategies rely on annual immunization and require frequent updates of the vaccine, which is not always a foolproof process. Furthermore, the current antivirals are also losing effectiveness as new viral strains are often refractory to conventional treatments. Thus, there is an urgent need to find new antiviral mechanisms and develop therapeutic drugs based on these mechanisms. Targeting the virus-host interface is an...
- Virus-Cell InteractionsThe Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species Specific
- Vaccines and Antiviral AgentsComparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection
- Genome Replication and Regulation of Viral Gene ExpressionDistribution of Hepatitis B Virus Nuclear DNA